Biohaven Pharmaceutical Holding Company Ltd.
USE OF RILUZOLE ORAL DISINTIGRATING TABLETS FOR TREATING DISEASES

Last updated:

Abstract:

Disclosed are methods of treating a disease in a patient in need thereof, comprising administering to the patient a pharmaceutical composition comprising a therapeutically effective amount of riluzole, or a pharmaceutically acceptable salt thereof, in the form of an oral solid molded fast-dispersing dosage form. Pharmaceutical compositions and kits are also disclosed.

Status:
Application
Type:

Utility

Filling date:

26 May 2019

Issue date:

14 Jul 2022